Jim Simons Finch Therapeutics Group, Inc. Transaction History

Renaissance Technologies LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.34 - $0.56 $10,166 - $16,744	-29,900 Reduced 24.33%	93,000 $37,000
Q4 2022 Feb 13, 2023	BUY	$0.36 - $1.26 $29,628 - $103,698	82,300 Added 202.71%	122,900 $59,000
Q3 2022 Nov 14, 2022	BUY	$1.75 - $2.88 $3,325 - $5,472	1,900 Added 4.91%	40,600 $68,000
Q2 2022 Aug 12, 2022	SELL	$1.91 - $5.11 $12,033 - $32,193	-6,300 Reduced 14.0%	38,700 $110,000
Q1 2022 May 13, 2022	BUY	$5.02 - $10.47 $36,716 - $76,577	7,314 Added 19.41%	45,000 $226,000

Q4 2021 Feb 11, 2022	BUY	$8.95 - $16.88 $337,289 - $636,139	37,686 New	37,686 $376,000

Ticker FNCH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,688,400
Market Cap $63.4M
Description
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.